SHARES PLUMMETS AFTER NOVO NORDISK DEAL COLLAPSE

Shares of HIMS experienced a dramatic drop today following the unexpected cancellation of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending HIMS's stock price plummeting by more than fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analysts speculate